Kubota Pharmaceutical Holdings Co., Ltd. provided consolidated earnings guidance for the fiscal year ending December 31, 2022. For the year, the company expects revenue of JPY 7 million, operating loss of JPY 2,000 million, net loss of JPY 2,000 million and basic loss per share of JPY 43.61.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
69 JPY | -1.43% | 0.00% | -13.75% |
1st Jan change | Capi. | |
---|---|---|
-13.75% | 2.56Cr | |
+37.78% | 71TCr | |
+32.82% | 58TCr | |
-3.51% | 36TCr | |
+19.94% | 33TCr | |
+5.14% | 29TCr | |
+16.64% | 24TCr | |
-4.13% | 21TCr | |
+10.63% | 21TCr | |
+9.32% | 17TCr |
- Stock Market
- Equities
- 4596 Stock
- News Kubota Pharmaceutical Holdings Co., Ltd.
- Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022